Rome IV Diagnostic Criteria for Functional Constipation

Rome IV C2 functional constipation: 2+ of 6 symptom features (>25% defecations or <3 spontaneous BMs/week), rare loose stools without laxatives, not IBS, 6-month onset and 3-month duration. Educational use only.

Rome IV Functional Constipation Diagnostic Criteria

Check the criteria that apply to the patient. The Rome IV criteria for functional constipation require at least 2 of 6 symptom criteria, loose stools rarely present without laxatives, insufficient criteria for IBS, and symptom duration of at least 3 months with onset at least 6 months before diagnosis.

Symptom criteria (at least 2 required)

Must include 2 or more of the following symptoms:

Exclusion criteria (all required)

Both of the following must be confirmed for a diagnosis of functional constipation.

Temporal criteria (required)

Both temporal requirements must be satisfied for a Rome IV diagnosis.

Disclaimer: The Rome IV diagnostic criteria for functional constipation are an educational clinical decision-support tool. They do not replace comprehensive clinical evaluation, appropriate diagnostic workup, or clinical judgment. Always ensure structural and organic causes of constipation (e.g., hypothyroidism, hypercalcaemia, colorectal obstruction, medication side effects) have been appropriately ruled out before applying these criteria. For research studies, patients meeting criteria for opioid-induced constipation should not receive a diagnosis of functional constipation.

Rome IV Criteria for Functional Constipation: formula, variables, and clinical context

Overview

The Rome IV diagnostic criteria for functional constipation were published in 2016 as part of the Rome IV classification of functional gastrointestinal disorders (disorders of gut-brain interaction). Functional constipation is categorised as C2 under bowel disorders. It is defined by a combination of symptoms including infrequent bowel movements, difficult stool passage, and/or a sense of incomplete defecation, in the absence of an organic cause and without meeting criteria for irritable bowel syndrome. The criteria require at least 2 of 6 symptom criteria to be present, with temporal thresholds ensuring chronicity.

Diagnostic criteria

Must include 2 or more of the following symptom criteria:

#	Symptom criterion	Threshold
1	Straining	> 25% of defecations
2	Lumpy or hard stools (BSFS 1-2)	> 25% of defecations
3	Sensation of incomplete evacuation	> 25% of defecations
4	Sensation of anorectal obstruction/blockage	> 25% of defecations
5	Manual maneuvers (e.g., digital evacuation, pelvic floor support)	> 25% of defecations
6	Fewer than 3 spontaneous bowel movements per week	< 3/week

Additional requirement	Details
Loose stools	Rarely present without the use of laxatives
IBS exclusion	Insufficient criteria for irritable bowel syndrome
Duration	Criteria fulfilled for the last 3 months
Onset	Symptom onset at least 6 months before diagnosis

Interpretation: If at least 2 of the 6 symptom criteria are present, loose stools are rarely seen without laxatives, IBS criteria are not met, and temporal requirements are fulfilled, the patient meets the Rome IV criteria for functional constipation (C2).

Bristol Stool Form Scale (BSFS)

The BSFS is a validated 7-point scale used to classify stool form. Types 1 and 2 indicate constipation; types 6 and 7 indicate diarrhoea.

Type	Description	Interpretation
1	Separate hard lumps (like nuts)	Severe constipation
2	Sausage-shaped but lumpy	Mild constipation
3	Sausage-shaped with cracks on surface	Normal
4	Smooth and soft sausage or snake	Ideal
5	Soft blobs with clear-cut edges	Lacking fibre
6	Fluffy pieces with ragged edges, mushy	Mild diarrhoea
7	Watery, no solid pieces	Severe diarrhoea

Rome IV uses BSFS types 1 and 2 (lumpy or hard stools) as the threshold for the hard stool criterion. Patients should ideally record stool form using a diary over 2 weeks.

Criterion definitions

Straining (> 25% of defecations)

Excessive muscular effort required to initiate or complete defecation. Patients report a need to push or bear down forcefully. Straining is one of the most commonly reported symptoms in functional constipation and often correlates with defecatory disorders (dyssynergic defecation).

Lumpy or hard stools (BSFS 1-2, > 25% of defecations)

Stool consistency is assessed using the Bristol Stool Form Scale. Types 1 (separate hard lumps) and 2 (sausage-shaped but lumpy) reflect prolonged colonic transit and excessive water absorption. Hard stool form is the most objective symptom criterion and correlates well with measured colonic transit time.

Sensation of incomplete evacuation (> 25% of defecations)

A subjective feeling that the rectum has not been fully emptied after defecation. This symptom may result from rectal hyposensitivity, retained stool, or pelvic floor dysfunction. It is a common feature of both slow-transit constipation and defecatory disorders.

Sensation of anorectal obstruction/blockage (> 25% of defecations)

The patient perceives a physical blockage preventing stool passage through the anal canal. This sensation is particularly suggestive of an evacuation disorder (e.g., dyssynergic defecation, rectocele, rectal intussusception) and may warrant anorectal physiology testing if persistent.

Manual maneuvers (> 25% of defecations)

The patient uses digital rectal evacuation, perineal splinting (pressing on the perineum or posterior vaginal wall), or other manual techniques to facilitate stool passage. This is a marker of significant evacuation difficulty and is particularly associated with pelvic floor dysfunction and rectocele.

Fewer than 3 spontaneous bowel movements per week

Reduced stool frequency, counted as complete spontaneous bowel movements (not assisted by laxatives). While stool frequency alone is a poor predictor of constipation (many constipated patients report daily bowel movements), infrequent defecation combined with other symptoms strengthens the diagnosis.

Loose stools rarely present without laxatives

This criterion excludes patients whose predominant stool pattern is loose or watery in the absence of laxative use. If loose stools frequently occur without laxatives, alternative diagnoses such as functional diarrhoea (C3) or IBS with mixed bowel habits (IBS-M) should be considered.

Insufficient criteria for IBS

The patient must not meet Rome IV criteria for irritable bowel syndrome: recurrent abdominal pain at least 1 day per week in the last 3 months, associated with defecation or a change in stool frequency or form. When both constipation symptoms and abdominal pain criteria are met, the diagnosis is IBS with predominant constipation (IBS-C) rather than functional constipation.

Functional constipation vs. IBS-C

A key clinical distinction in Rome IV is between functional constipation (C2) and constipation-predominant IBS (IBS-C). The differentiating factor is the presence and nature of abdominal pain:

Feature	Functional constipation (C2)	IBS-C (C1)
Abdominal pain	Absent or not prominent; does not meet IBS pain criteria	Recurrent, at least 1 day/week, related to defecation
Constipation symptoms	At least 2 of 6 symptom criteria	Predominant constipation pattern (> 25% hard stools)
Stool form	BSFS 1-2 predominates	> 25% BSFS 1-2 and < 25% BSFS 6-7
Treatment focus	Fibre, osmotic laxatives, prokinetics, biofeedback	Secretagogues, neuromodulators, diet, psychological therapies

Rome IV acknowledges that these conditions may exist on a spectrum. Some patients may transition between FC and IBS-C over time, and therapeutic overlap exists.

Pathophysiological subtypes

While Rome IV does not formally subclassify functional constipation, three pathophysiological subtypes are recognised and guide management:

Subtype	Mechanism	Typical features	Diagnostic test
Normal-transit constipation	Normal colonic motility; symptoms driven by perception	Hard stools, straining; normal transit on testing	Colonic transit study (normal)
Slow-transit constipation	Reduced colonic motor activity; prolonged whole-gut transit	Infrequent bowel movements, bloating, minimal urge to defecate	Colonic transit study (delayed); wireless motility capsule
Defecatory disorders (dyssynergia)	Impaired rectal evacuation due to pelvic floor dyscoordination or structural abnormality	Excessive straining, obstruction sensation, manual maneuvers, incomplete evacuation	Anorectal manometry, balloon expulsion test, defecography

Overlap between subtypes is common. Approximately 50% of patients with slow-transit constipation also have a defecatory disorder.

Treatment considerations

Step	Approach	Details
1	Lifestyle and dietary measures	Adequate fluid intake, increased dietary fibre (25-30 g/day), regular physical activity, and establishing a consistent toilet routine.
2	Fibre supplementation	Soluble fibre (e.g., psyllium) is preferred over insoluble fibre (e.g., wheat bran), which may worsen bloating. Titrate slowly to minimise gas and distension.
3	Osmotic laxatives	Polyethylene glycol (PEG, macrogol) is first-line pharmacotherapy with strong evidence. Lactulose is an alternative.
4	Stimulant laxatives / secretagogues	Bisacodyl or sodium picosulphate for rescue. Secretagogues (linaclotide, plecanatide, lubiprostone) for refractory cases with evidence of benefit.
5	Prokinetics	Prucalopride (5-HT4 agonist) for slow-transit constipation refractory to laxatives.
6	Biofeedback	First-line for defecatory disorders (dyssynergic defecation). Evidence supports superiority over laxatives in this subgroup.

Epidemiology

Prevalence: Chronic constipation affects approximately 10-15% of adults worldwide. When Rome IV criteria are strictly applied, the prevalence of functional constipation is estimated at 5-10%.
Sex distribution: More common in women than men, with a female-to-male ratio of approximately 2-3:1.
Age: Prevalence increases with age, particularly after age 65. However, functional constipation can affect all age groups including children and young adults.
Economic burden: Chronic constipation accounts for millions of healthcare visits annually and significant costs related to prescription laxatives, diagnostic testing, and reduced work productivity.
Quality of life: Functional constipation significantly impairs health-related quality of life, comparable to other chronic conditions such as diabetes and heart disease.

Limitations

Symptom-based diagnosis: Like all Rome criteria, the diagnosis relies on patient-reported symptoms, which are subject to recall bias and variable interpretation. Stool diaries can improve accuracy.
The 25% threshold: The > 25% threshold for symptom criteria is somewhat arbitrary and may be difficult for patients to estimate precisely. It serves as a clinical approximation rather than a precise measurement.
Overlap with IBS-C: The distinction between functional constipation and IBS-C depends on the presence and prominence of abdominal pain, which can be subjective and may fluctuate over time. Some experts consider these conditions to be on a spectrum.
Opioid-induced constipation: For research purposes, patients meeting criteria for opioid-induced constipation should not receive a diagnosis of functional constipation. In clinical practice, these conditions frequently overlap, particularly in chronic pain populations.
Secondary causes: The Rome IV criteria should be applied only after excluding secondary causes of constipation (hypothyroidism, hypercalcaemia, medications, structural lesions, neurological conditions). The criteria themselves do not guide the exclusion workup.

Key references

Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407.e5.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262-1279.e2.
Bharucha AE, Lacy BE. Mechanisms, evaluation, and management of chronic constipation. Gastroenterology. 2020;158(5):1232-1249.e3.
Rao SSC, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430-1442.e4.
Camilleri M, Ford AC, Mawe GM, et al. Chronic constipation. Nat Rev Dis Primers. 2017;3:17095.
Palsson OS, Whitehead WE, van Tilburg MAL, et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology. 2016;150(6):1481-1491.

Practice caveats

The Rome IV criteria are symptom-based and assume that structural and metabolic causes of constipation have been appropriately excluded. A thorough history, medication review, and targeted investigations (thyroid function, calcium, colonoscopy if alarm features are present) should precede application of these criteria.
The distinction between functional constipation and IBS-C hinges on whether abdominal pain is a prominent feature associated with bowel habit changes. In borderline cases, clinical judgment should guide classification and treatment.
For patients refractory to empiric laxative therapy, physiological testing (colonic transit study, anorectal manometry, balloon expulsion test) should be performed to identify slow-transit constipation and/or defecatory disorders, which require targeted management.
For research studies, patients meeting criteria for opioid-induced constipation should not receive a functional constipation diagnosis. In clinical practice, overlap between these conditions is common and both may need to be addressed.

What functional constipation means in Rome IV

Functional constipation (Rome IV category C2) is a chronic disorder of bowel habit defined by a cluster of defecation-related symptoms rather than by a single laboratory value or imaging finding. It sits within the Rome bowel disorders chapter alongside irritable bowel syndrome and other functional diagnoses. The criteria aim to identify patients whose constipation pattern is stable enough to study and treat as a functional syndrome while separating them from people whose symptoms are better explained by IBS or frequent loose stools.

Core symptom rule: at least two of six features

The diagnosis requires two or more of the following. For items (a) through (e), each should occur during more than 25% of defecations (roughly, more than one in four bowel movements over the relevant reporting window). Item (f) uses a weekly frequency threshold instead of a percentage.

(a) Straining

Excessive pushing or prolonged effort to pass stool, present on a minority-but-substantial fraction of bowel movements when viewed across time, not only during isolated episodes.

(b) Lumpy or hard stools (Bristol Stool Form Scale types 1 to 2)

Type 1 describes separate hard lumps; type 2 is sausage-shaped but lumpy. Using BSFS anchors reduces vague descriptors like “constipated” and aligns clinician and patient language.

(c) Sensation of incomplete evacuation

A persistent feeling that stool remains in the rectum after attempting to defecate. This symptom overlaps with dyssynergic defecation and pelvic floor dysfunction, which may coexist and often merit targeted evaluation when symptoms are refractory.

(d) Sensation of anorectal obstruction or blockage

The patient describes a mechanical barrier sensation even when stool is soft. This is distinct from simple slow transit and may prompt consideration of coordinated anorectal testing in appropriate cases.

(e) Manual maneuvers to facilitate defecation

Examples include digital disimpaction, perineal or vaginal splinting, or other physical techniques used repeatedly to complete evacuation. Frequent reliance on such maneuvers signals significant outlet dysfunction until proven otherwise.

(f) Fewer than three spontaneous bowel movements per week

Here “spontaneous” means without rescue laxatives or enemas used for that movement. This criterion captures infrequent complete evacuations even if some of the percentage-based symptoms are less prominent.

Exclusion-style requirements

Two additional conditions must be satisfied.

Loose stools are rarely present without laxatives

Off laxative therapy, the patient should not regularly pass loose or watery stools (BSFS types 6 to 7). Frequent loose stools in the absence of laxatives suggests alternative diagnoses (for example diarrhea-predominant processes, overflow, or disorders better classified outside isolated functional constipation).

Insufficient criteria for irritable bowel syndrome

If Rome IV IBS is met, the constipation label shifts toward IBS with constipation (IBS-C) rather than standalone functional constipation. Rome IV IBS centers on recurrent abdominal pain at least one day per week (in the last three months) together with a link to defecation and/or changes in stool frequency or form. Functional constipation can coexist with discomfort, but the full IBS phenotype supersedes C2 when those IBS thresholds are fulfilled.

Temporal requirements

Six-month onset: symptoms began at least six months before the assessment.
Three-month persistence: the defining symptom pattern has been present for the most recent three months, aligning Rome IV timing across bowel disorders.

How the CalcMD checklist works

The calculator lists all six symptom items; internally, meeting functional constipation requires at least two affirmative answers among them. It then requires both exclusion items and both temporal items to be affirmative for an overall positive result. This mirrors the module logic in the application.

Clinical context beyond the checklist

Rome criteria do not replace evaluation for secondary causes when red flags or risk factors exist (for example new onset in older adults, unexplained weight loss, iron deficiency anemia, or focal neurology). Medications, endocrine disorders, metabolic disturbances, and structural colorectal disease remain important competing explanations. In research settings, patients meeting criteria for opioid-induced constipation are often analyzed separately from functional constipation, though real-world overlap is recognized.

Important limitations

This article and tool are for education and structured criterion review, not autonomous diagnosis or treatment decisions.
Patient diaries, BSFS training, and medication history materially affect whether the 25% thresholds are met.
Refractory symptoms may indicate anorectal physiology testing or pelvic floor therapy pathways even when Rome IV C2 is satisfied.